This playbook is intended to support sites interested in administering COVID-19 treatment under EUA including:
• Existing hospital or community-based infusion centers
• Existing clinical space (e.g. urgent care, emergency depts)
• Ad hoc new infusion sites (e.g. “hospitals without walls”)
• Long-term care facilities or home infusions with infusion delivery capability
Most US school districts as of 23 March 2020 are and will remain closed until the end of the academic school year or “until further notice” because of COVID-19, according to data provided by a Maryland-based online publication that provides scholastic news and analysis. This Article assumes that while pre-kindergarten through 12th grade schools, institutions of higher education, and business and trade schools are closed, many are relying on internet-enabled distance learning (eLearning) alternatives in place of traditional classroom instruction.
The FBI’s Minneapolis Division, in coordination with the Office of Private Sector (OPS), Criminal Investigative Division (CID), and 3M, prepared this LIR to make the Healthcare and Public Health Sectors aware of indicators related to fraudulent sales solicitation of 3M Personal Protective Equipment (PPE), or indicators of counterfeit 3M PPE, including N95 respirators.
APT actors likely will identify new or use existing vulnerabilities in Zoom to compromise user devices and accounts for further exploitation of corporate networks. This judgment includes critical infrastructure entities using Zoom. We base this judgment on recent public exposure of Zoom’s numerous vulnerabilities. While vendors regularly publish patches for vulnerabilities, reports indicate there are instances in which users and organizations delay updates. The patching process is undermined by APT actors who often capitalize on delays and develop exploits based on the vulnerability and available patches.
The COVID-19 virus is a new pathogen that is highly contagious, can spread quickly, and must be considered capable of causing enormous health, economic and societal impacts in any setting. It is not SARS and it is not influenza. Building scenarios and strategies only on the basis of well-known pathogens risks failing to exploit all possible measures to slow transmission of the COVID-19 virus, reduce disease and save lives.
Outbreaks of novel virus infections among people are always of public health concern. The risk from these outbreaks depends on characteristics of the virus, including whether and how well it spreads between people, the severity of resulting illness, and the medical or other measures available to control the impact of the virus. Investigations are ongoing to learn more, but some degree of person-to-person spread of 2019-nCoV is occurring. It is not clear yet how easily 2019-nCoV spreads from person-to-person. While CDC considers this as a serious public health concern, based on current information, the immediate health risk from 2019-nCoV to the general American public is considered low at this time.